Long flights, demanding work schedules, Florida's heat, and days spent exploring Disney or Universal can leave you feeling physically drained
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
So, it might enable athletes to recover faster from hard training sessions, which would enhance their performance in the long run
What you get: Unlimited access to articles Get all four HHP monthly newsletters straight to your inbox Subscriber-only articles Full access to A to Z comprehensive library Quizzes, health tips and more
It has a short half life (30 minutes)